Pulmonary Vascular Disease Phenomics Program PVDOMICS

ClinicalTrials.gov ID: NCT02980887

Public ClinicalTrials.gov record NCT02980887. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics (PVDOMICS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

It is recognized that patients with various forms of heart and lung disease exhibit varying degrees of pulmonary hypertension, pulmonary vascular remodeling, and right ventricular dysfunction. The genetic, molecular, and cellular processes driving these phenomena are not well understood. Rapid advances in high throughput omic methodology, combined with powerful bioinformatics and network biology capability, have created the opportunity to conduct studies that broadly search for homologies and differences across the spectrum of disease states associated with pulmonary hypertension, and determinants of the spectrum of right ventricular compensation that accompanies these conditions

Study identification

NCT ID: NCT02980887
Recruitment status: Active, not recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: The Cleveland Clinic; Other
Enrollment: 1,195 participants

Conditions and interventions

Conditions

Pulmonary Arterial Hypertension

Interventions

No Intervention Other

Other

Eligibility (public fields only)

Age range: 18 Years to 100 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 2016 (Type not available)
Primary completion: Dec 31, 2029 (Estimated)
Completion: Dec 31, 2029 (Estimated)
Last update posted: Sep 9, 2026

2016 – 2029

United States locations

U.S. sites: 7
U.S. states: 6
U.S. cities: 7

Facility	City	State	ZIP	Site status
University of Arizona Health Sciences Center	Tucson	Arizona	85721	—
Johns Hopkins University School of Medicine	Baltimore	Maryland	21287	—
Brigham and Women's Hospital	Boston	Massachusetts	02115	—
Mayo Clinic	Rochester	Minnesota	55905	—
Weill Cornell Medicine	New York	New York	10065	—
New York Medical College	Valhalla	New York	10595	—
Vanderbilt University Medical Center	Nashville	Tennessee	37232	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02980887, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 9, 2026 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02980887 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →